Maximus is executing a successful operational turnaround, evidenced by gross margin expansion to 27.3% in Q3 FY2026 from 25.0% a year earlier and a recovery in net margin from a 2.9% trough in Q1 FY2025 to 8.1%. However, the company faces significant headwinds...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $2.22+0.5% vs $2.21 | $1.3B-3.7% vs $1.3B |
Q2 2026 May 7, 2026 | $2.07+4.5% vs $1.98 | $1.3B-0.6% vs $1.3B |
Q1 2026 Feb 5, 2026 | $1.85+0.5% vs $1.84 | $1.3B-2.2% vs $1.4B |
Q4 2025 Nov 20, 2025 | $1.62-3.0% vs $1.67 | $1.3B-1.7% vs $1.3B |
[url="]LitePoint[/url], a leading provider of communication test solutions, today announced the successful validation of physical layer (PHY) performance for ST
Bank of America Corp DE lessened its position in Maximus, Inc. (NYSE: MMS) by 19.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 563,486 shares of the health services provider's stock after selling 137,118 shares during the quarter. Bank of America Corp
Maximus faces an earnings reset as paused VA incentives cut profit and cash-flow guidance, testing whether service and tech gains can rebuild momentum.
Maximus trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery.
Benchmark MMS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Maximus, Inc. (MMS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $53.79 | $2.83B | 9.76 | 2.36% | 5.87% | 18.14% | 2.21% | |
| $616.68 | $13.62B | 25.52 | 10.89% | 5.6% | 12.68% | — | |
| $132.96 | $5.62B | 17.27 | -2.9% | 5.13% | 25.89% | — | |
| $124.69 | $15.68B | 11.20 | 3.07% | 7.67% | 26.38% | — | |
| $75.65 | $9.1B | 10.95 | -6.37% | 7.01% | 71.9% | — | |
| $30.21 | $1.84B | -1.48 | 2.15% | -13.15% | -41.8% | — |
Maximus, Inc. (MMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Maximus, Inc. (MMS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
May 28, 2026·SEC
May 7, 2026·SEC
Get notified when MMS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Maximus, Inc. (MMS) stock FAQ — growth, dividends, profitability & financials explained
Maximus, Inc. (MMS) reported $5.25B in revenue for fiscal year 2025. This represents a 4991% increase from $103.1M in 1996.
Maximus, Inc. (MMS) grew revenue by 2.4% over the past year. Growth has been modest.
Yes, Maximus, Inc. (MMS) is profitable, generating $370.9M in net income for fiscal year 2025 (5.9% net margin).
Yes, Maximus, Inc. (MMS) pays a dividend with a yield of 2.21%. This makes it attractive for income-focused investors.
Maximus, Inc. (MMS) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.
Maximus, Inc. (MMS) generated $433.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
